Nonprenylated Rotenoids, a New Class of Potent Breast Cancer Resistance Protein Inhibitors
Authors:
- 7 March 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 50 (8) , 1933-1938
Abstract
Two rotenoids isolated from Boerhaavia diffusa (Nyctaginaceae), boeravinones G (1) and H (2), have been found to potently inhibit the drug efflux activity of breast cancer resistance protein (BCRP/ABCG2), a multidrug transporter responsible for cancer cell resistance to chemotherapy. The isolation of nine additional rotenoid derivatives (3 − 11), including the new boeravinones I (10) and J (11), from the extract of B. diffusa roots allowed us to establish structure−activity relationships toward inhibition of BCRP-mediated drug transport activity. The results show the positive roles of a methoxy group at position 6 of ring B and the absence of a substituent at position 10, and the requirement for a 6a/12a double bond between rings B and C. In contrast, both contraction of ring B, to give a coumaronochromone (11), and tetrasubstitution of ring D appeared to be detrimental for the inhibitory potency. The present study provides the first data on the BCRP-inhibiting activity of rotenoid derivatives, indicating boeravinones as a new class of interesting BCRP inhibitors.Keywords
This publication has 18 references indexed in Scilit:
- Spasmolytic Effects of Nonprenylated Rotenoid Constituents of Boerhaavia diffusa RootsJournal of Natural Products, 2006
- Isolation of New Rotenoids fromBoerhaavia diffusaand Evaluation of their Effect on Intestinal MotilityPlanta Medica, 2005
- Flavonoid Structure-Activity Studies Identify 6-Prenylchrysin and Tectochrysin as Potent and Specific Inhibitors of Breast Cancer Resistance Protein ABCG2Cancer Research, 2005
- ABCG2 – a transporter for all seasonsFEBS Letters, 2004
- Jatrophane Diterpenes as Modulators of Multidrug Resistance. Advances of Structure−Activity Relationships and Discovery of the Potent Lead Pepluanin AJournal of Medicinal Chemistry, 2004
- Modulation of P‐glycoprotein but not MRP1‐ or BCRP‐mediated drug resistance by LY335979International Journal of Cancer, 2002
- Frequent expression of the multi‐drug resistance‐associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP‐21 monoclonal antibody in paraffin‐embedded materialThe Journal of Pathology, 2002
- The rotenoid core structure: Modifications to define the requirements of the toxophore.Bioorganic & Medicinal Chemistry Letters, 1992
- Two New Isoflavonoids from Boerhaavia, coccineaJournal of Natural Products, 1991
- Interaction of 8-anilinonaphthalene-1-sulfonate with .ALPHA.-cyclodextrin.Chemical and Pharmaceutical Bulletin, 1991